SEARCH

SEARCH BY CITATION

References

  • 1
    Martin P, Friedman LS. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995; 47: 123141.
  • 2
    Burdick RA, Bragg-Cresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2002; 63: 22229.
  • 3
    Finelli L, Miller JT, Tokars JL, Alter MJ, Arduino M. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 5261.
  • 4
    Teles SA, Martins RMB, Gomes SA, et al. Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up. J Med Virol 2002; 68: 419.
  • 5
    Igaki N, Nakaji M, Moriguchi R, et al. An outbreak of fulminant hepatitis in immunocompromised hemodialysis patients. J Gastroenterol 2003; 38: 96876.
  • 6
    Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: The effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 2004; 20: 105362.
  • 7
    Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W and The Dialysis Vaccine Trial Study Group. Hepatitis B vaccine in patients receiving hemodialysis. N Engl J Med 1984; 311: 496501.
  • 8
    Vagelli G, Calabrese G, Mazzotta A, Pratesi G, Gonella M. More about response to hepatitis B vaccine in hemodialysis patients. Nephron 1988; 49: 171 [letter].
  • 9
    Fernandez E, Betru MA, Gomez R, Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996; 11: 155963.
  • 10
    Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 1996; 16: 957.
  • 11
    Ahuja TS, Kumar S, Mansoury H, Rodriguez H, Kuo YF. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis. Kidney Int 2005; 67: 113641.
  • 12
    Fabrizi F, Di Filippo S, Marcelli D, et al. Recombinant hepatitis B vaccine use in chronic hemodialysis patients: long-term evaluation and cost-effectiveness analysis. Nephron 1996; 72: 53643.
  • 13
    Pol S, Legendre C, Mattlinger B, Berthelot P, Krein H. Genetic basis of nonresponse to hepatitis B vaccine in hemodialysis patients. J Hepatol 1990; 11: 3857.
  • 14
    Sennesael JJ, van der Niepen P, Verbeelen DL. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991; 40: 1218.
  • 15
    Jibani MM, Heptonstall J, Walker AM, Bloodworth LO, Howard AJ. Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol Dial Transplant 1994; 9: 17658.
  • 16
    Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardoski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 44852.
  • 17
    Touraine JL, Touraine F, Revillard JP, Brochier J, Traeger J. T lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron 1975; 14: 195298.
  • 18
    Poynard T, Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature: a comparison of MEDLARS and manual methods. Control Clin Trials 1985; 6: 2719.
  • 19
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1985; 6: 2719.
  • 20
    Majdan M, Polz M, Ksiazek A, et al. The response to the hepatitis B virus vaccine in hemodialyzed and peritoneal dialyzed patients: own experiences. Przegl Lek 1995; 52: 30710.
  • 21
    Liu YL, Kao MT, Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005; 23: 395760.
  • 22
    Schmid E, Augustin R, Machleidt C, Wisser H, Kuhlmann U. Efficacy of hepatitis B vaccination in patients on CAPD compared to patients on hemodialysis. Adv Perit Dial 1987; 1: 15.
  • 23
    Steketee RW, Ziarnick ME, Davis JP. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 1988; 127: 77282.
  • 24
    Drachman R, Isacsohn M, Rudenski B, Drukker A. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 1989; 4: 3724.
  • 25
    Khan AN, Bernardini J, Rault RM, Piraino B. Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Perit Dial Int 1996; 16: 3703.
  • 26
    Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron 1996; 73: 41720.
  • 27
    Dumann H, Meuer S, Meyer zum Buschenfelde KH, Kohler H. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. Kidney Int 1990; 38: 11648.
  • 28
    Egea E, Iglesias A, Salazar M, et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991; 173: 5318.
  • 29
    Verkade MA, van de Wtering J, Klepper M, Vaessen LMB, Weimar W, Betjes GHM. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int 2004; 66: 61421.
  • 30
    Rangel MC, Coronado V, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis. Semin Dial 2002; 13: 1017.
  • 31
    Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B revaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997; 12: 120411.
  • 32
    DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003; 42: 118492.
  • 33
    Zaruba K, Grob PJ, Bolla K. Thymopentin as adjuvant therapy to hepatitis B vaccination in formerly non or hyporesponding hemodialysis patients. Surv Immunol Res 1985; 4 (Suppl. 1): 1026.
  • 34
    Hassan K, Shternberg L, Alhaj M, et al. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease. Ren Fail 2003; 25: 4718.
  • 35
    Rawer P, Willems WR, Breidenbach TH, Guttmann W, Pabst W, Schutterle G. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation. Kidney Int 1987; 32: 14952.
  • 36
    Mauri MJ, Valles M and The Collaborative Groups of Girona. Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients. Nephrol Dial Transplant 1997; 12: 72932.
  • 37
    Quiroga JA, Castillo I, Porres JC, et al. Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients. Hepatology 1990; 12: 6613.
  • 38
    Tong NKC, Beran J, Kee SA, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005; 68: 2298303.
  • 39
    Fabrizi F, Martin P. Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 2001; 24: 68394.
  • 40
    Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus M. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 2005; 9: 36775.
  • 41
    Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic haemodialysis patients. MMWR 2001; 50(RR 5): 143.
  • 42
    Michel P, Janin G, El Yafi S, et al. Improvement of immune response in dialysis patients to Hevac B vaccine after multiple injections of vaccine. Proc EDTA ERA 1985; 22: 107782.
  • 43
    Moxey-Mims MM, Preston K, Fivush B, McCurdy F (Chesapeake Pediatric Nephrology Study Group). Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Pediatr Nephrol 1990; 4: 1714.
  • 44
    Fleming SJ, Moran DM, Cooksley WGE, Faoagali JL. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991; 22: 2517.
  • 45
    El-Reshaid K, Al Mufti S, Johny KV, Sugathan TN. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 1994; 12: 2238.
  • 46
    Fraser GM, Ochana N, Fenyves D, et al. Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients. J Hepatol 1994; 21: 4504.
  • 47
    Bel'eed K, Wright M, Eadington D, Farr M, Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 2002; 78: 53840.
  • 48
    Watkins SL, Alexander SR, Brewer ED, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 2002; 40: 36572.